Small molecule screening in zebrafish: swimming in potential drug therapies

Phenotype‐driven chemical genetic screens in zebrafish have become a proven approach for both dissection of developmental mechanisms and discovery of potential therapeutics. A library of small molecules can be arrayed into multiwell plates containing zebrafish embryos. The embryo becomes a whole organism in vivo bioassay that can produce a phenotype upon treatment. Screens have been performed that are based simply on the morphology of the embryo. Other screens have scored complex phenotypes using whole mount in situ hybridization, fluorescent transgenic reporters, and even tracking of embryo movement. The availability of many well‐characterized zebrafish mutants has also enabled the discovery of chemical suppressors of genetic phenotypes. Importantly, the application of chemical libraries that already contain FDA‐approved drugs has allowed the rapid translation of hits from zebrafish chemical screens to clinical trials. WIREs Dev Biol 2012, 1:459–468. doi: 10.1002/wdev.37

[1]  L. Zon,et al.  Effects of RAS on the genesis of embryonal rhabdomyosarcoma. , 2007, Genes & development.

[2]  Richard M White,et al.  Chemical genetic screening in the zebrafish embryo , 2009, Nature Protocols.

[3]  Audrey White,et al.  Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. , 2007, Cancer research.

[4]  M. Huffman,et al.  Fish Embryos as Bio-Assay Material in Testing Chemicals for Effects on Cell Division and Differentiation , 1957 .

[5]  Martin Distel,et al.  Global repression of cancer gene expression in a zebrafish model of melanoma is linked to epigenetic regulation. , 2009, Zebrafish.

[6]  J. Davison,et al.  Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. , 2008, Gastroenterology.

[7]  J. Dowling,et al.  Small molecule developmental screens reveal the logic and timing of vertebrate development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Haggarty,et al.  Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation , 2010, Science.

[9]  Christian Laggner,et al.  Rapid behavior—based identification of neuroactive small molecules in the zebrafish , 2009, Nature chemical biology.

[10]  S. Leach,et al.  Zebrafish models for cancer. , 2011, Annual review of pathology.

[11]  J. Abian,et al.  Fish proteome analysis: Model organisms and non‐sequenced species , 2010, Proteomics.

[12]  Charles Y. Lin,et al.  DHODH modulates transcriptional elongation in the neural crest and melanoma , 2011, Nature.

[13]  L. Zon,et al.  tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Ivet Bahar,et al.  Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages , 2009, Nature chemical biology.

[15]  L. Zon,et al.  Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish. , 2009, Zebrafish.

[16]  L. Zon,et al.  Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish , 2007, Proceedings of the National Academy of Sciences.

[17]  Ying Cao,et al.  Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models , 2009, Proceedings of the National Academy of Sciences.

[18]  Stuart L Schreiber,et al.  Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation , 2004, Nature Biotechnology.

[19]  L. Zon,et al.  A Chemical Genetic Screen for Cell Cycle Inhibitors in Zebrafish Embryos , 2006, Chemical biology & drug design.

[20]  Mehmet Fatih Yanik,et al.  High-throughput in vivo vertebrate screening , 2010, Nature Methods.

[21]  David M Langenau,et al.  Myc-Induced T Cell Leukemia in Transgenic Zebrafish , 2003, Science.

[22]  A. Look,et al.  NOTCH1-induced T-cell leukemia in transgenic zebrafish , 2007, Leukemia.

[23]  Michael Tsang,et al.  Development of automated imaging and analysis for zebrafish chemical screens. , 2010, Journal of visualized experiments : JoVE.

[24]  A. Look,et al.  NOTCH1-Induced T-Cell Leukemia in Transgenic Zebrafish. , 2006 .

[25]  L. Zon,et al.  Small molecule screen in zebrafish and HSC expansion. , 2010, Methods in molecular biology.

[26]  R. Peterson,et al.  AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression , 2007, Development.

[27]  Young-Hoon Ahn,et al.  Tagged small molecule library approach for facilitated chemical genetics. , 2007, Accounts of chemical research.

[28]  J S Driscoll,et al.  The preclinical new drug research program of the National Cancer Institute. , 1984, Cancer treatment reports.

[29]  L. Zon,et al.  Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis , 2007, Nature.

[30]  Charles C Hong,et al.  Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. , 2008, Nature chemical biology.

[31]  L. Zon,et al.  A New System for the Rapid Collection of Large Numbers of Developmentally Staged Zebrafish Embryos , 2011, PloS one.

[32]  H. Tsai,et al.  TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia , 2006, Proceedings of the National Academy of Sciences.

[33]  Kathryn E. Crosier,et al.  Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. , 2002, Development.

[34]  Randall W King,et al.  Small molecules that delay S phase suppress a zebrafish bmyb mutant , 2005, Nature chemical biology.

[35]  Michael Tsang,et al.  Automated image‐based phenotypic analysis in zebrafish embryos , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[36]  K. K. Hisaoka,et al.  Some effects of barbituric and diethylbarbituric acid on the development of the zebra fish, Brachydanio rerio , 1957, The Anatomical record.

[37]  L. Zon,et al.  BRAF Mutations Are Sufficient to Promote Nevi Formation and Cooperate with p53 in the Genesis of Melanoma , 2005, Current Biology.

[38]  M. Condron,et al.  Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion. , 2005, Experimental hematology.